Cover Image
市場調查報告書

全球內臟器官·組織移植市場

Organ and Tissue Transplantation

出版商 Global Industry Analysts, Inc. 商品編碼 236773
出版日期 內容資訊 英文 251 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球內臟器官·組織移植市場 Organ and Tissue Transplantation
出版日期: 2014年09月01日 內容資訊: 英文 251 Pages
簡介

本報告提供全球內臟器官·組織移植市場相關調查,為您彙整美國,加拿大,日本,歐洲,亞太地區,南美等地區別分析,今後的市場預測,及打入市場的主要企業簡介等資料。

第1章 簡介,調查方法,產品定義

第2章 摘要整理

  • 市場概要
    • 概要
    • 歐洲及美國推動市場
    • 腎臟及肝臟移植居全球器官移植的首位
    • 需求與供給的不平衡
    • 內臟器官不足的對策
    • 心臟病發作致死者
    • 由於循環系統而死亡後的內臟器官捐贈
    • 生物間移植的增加
    • 移植:費用和各地區差異
    • 人工骨:概要
    • 全球整形外科產業的主要統計
    • 整形外科用移植:各地區市場差異
  • 市場趨勢
    • 合併器官移植
    • 違法販賣器官
    • 同意率的上升
    • 移植旅遊觀光事業
    • 為達成重要作用的合作
    • 高齡化和慢性疾病提高移植的需求 其他
  • 技術創新
    • 3D生物印刷
    • Preloaded Corneal Tissue Cartridges
    • 肺灌流技術
  • 移植影響市場的主要課題
    • 內臟器官排斥反應
    • 對捐贈者內臟器官的疑慮
    • 器官移植的其他問題
    • 移植的倫理性問題
    • 生物倫理性問題阻礙內臟器官提供流程
    • 必要的專門性不足:阻礙了移植流程
    • 發展中國家的角膜移植:主要課題
  • 產品概要
    • 器官移植
    • 心臟移植
    • 腎臟移植
    • 肝臟移植
    • 胰臟移植
    • 小腸移植
    • 心肺移植
    • 肺移植
    • 組織移植
    • 移植的種類
    • 角膜移植
    • 血液幹細胞
    • 骨·組織移植
    • 骨髓移植
    • 心臟瓣膜 其他
  • 人造器官
  • 保存液和免疫抑制劑
  • 法律制度
  • 產品開發/技術創新
  • 近幾年的產業活動
  • 主要企業
  • 全球市場預測

第3章 市場

  • 美國
  • 加拿大
  • 歐洲
  • 亞太地區
  • 南美
  • 其他

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP-1572

This report analyzes the worldwide markets for Organ and Tissue Transplantation in Number of Procedures. The global and regional markets (except the US) for 'Organ and Tissue Transplantation' in this report are analyzed by the following Product Segments - Organ Tranplantation (Heart, Kidneys, Liver, Pancreas, and Lungs). The US market for 'Organ and Tissue Transplantation' in this report is analyzed by the following Product Segments: Organ Type (Heart, Kidneys, Liver, Pancreas, Lungs, and Intestine), Tissue Type (Cornea, Heart Valve, Skin Grafts, Vascular Grafts, Bone Marrow, and Bone Grafts), and Bone Graft Transplantation (By Graft Type: Autologous Graft, Allograft, and Other Materials; By Application Type: General Orthopedics, Spinal Fusions, and Cranio/Maxillofacial). The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 24 companies including many key and niche players such as -

CryoLife, Inc.
Exactech, Inc.
Folio Biosciences
Kohler Chemie
LifeCell Corporation

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definition and Scope of Study
  • Product Definitions
    • Organ Transplantation
      • Heart Transplantation
      • Kidney Transplantation
      • Liver Transplantation
      • Pancreas Transplantation
      • Small Intestine Transplantation
      • Lungs
    • Tissue Transplantation
      • Corneal Transplantation
      • Blood Stem Cell Transplantation
      • Bone Marrow Transplantation
      • Heart Valves Transplantation

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • A Quick Primer...
  • Europe and the United States Lead the Global Organ Transplants Market
    • Table 1: Global Organ Transplants by Leading Country in Terms of No. of Transplants Per Million Population (PMP) for the Year 2012 (includes corresponding Graph/Chart)
  • Kidney and Liver Transplants Top the Organ Transplants Worldwide
    • Table 2: Global Kidney Transplants from Deceased Donor by Select Countries (2013): No. of Transplants Per Million Population (PMP) by Country (includes corresponding Graph/Chart)
    • Table 3: Global Kidney Transplants from Living Donor by Select Countries (2013): No. of Transplants per Million Population (PMP) by Country (includes corresponding Graph/Chart)
    • Table 4: Global Liver Transplants from Deceased Donor by Select Countries (2013): No. of Transplants per Million Population (PMP) by Country (includes corresponding Graph/Chart)
    • Table 5: Global Liver Transplants from Living Donor by Select Countries (2013): No. of Transplants per million population (PMP) by Country (includes corresponding Graph/Chart)
    • Table 6: Global Heart Transplants by Select Countries (2013): No. of Transplants Per million population (includes corresponding Graph/Chart)
    • Table 7: Global Lung Transplants by Select Countries (2013): Number of Transplants Per Million Population (includes corresponding Graph/Chart)
    • Table 8: Global Pancreas Transplants by Select Countries (2013): Number of Transplants Per Million Population (includes corresponding Graph/Chart)
  • Demand and Supply Imbalance
    • Table 9: European Organ Transplantation Waiting Lists: No. of Waiting Patients by Organ Type (2012) (includes corresponding Graph/Chart)
    • Table 10: US Waiting List of Patients for Organ Transplants by Organ Type: As of August 2014 (includes corresponding Graph/Chart)
  • Measures to Address Organ Shortage...
  • Cardiac Arrest Death Patients: The Untapped Potential Donors
    • Table 11: Leading Countries in Terms of Number of Donors after Cardiac Death (DCD) in 2013 (includes corresponding Graph/Chart)
  • Donation after Circulatory Death - Rife with Ethical Issues
  • Living Donor Organs on the Rise
    • Table 12: Global Living Organ Donors by Leading Country in Terms of No. of Donors Per Million Population (PMP) for the Year 2013 (includes corresponding Graph/Chart)
    • Table 13: Global Deceased Organ Donors by Leading Country in Terms of No. of Donors Per Million Population (PMP) for the Year 2013 (includes corresponding Graph/Chart)
  • Transplantation - Expenditure and Regional Variations
    • Table 14: US Organ Transplantation Charges - Total Billed Charges per Transplant by Type (2011) (includes corresponding Graph/Chart)
  • Bone Grafts: An Overview
    • Table 15: Fractures by Age Group (2012): Percentage Share Breakdown of Number of Fractures by Age Group (includes corresponding Graph/Chart)
    • Table 16: Global Orthopedic Market by Segment (2013E): Percentage Breakdown of Value Sales for Spine, Trauma, Knees, Hips, Orthobiologics, Extremities and Others (includes corresponding Graph/Chart)
  • Key Statistics in Global Orthopedics Industry
    • Table 17: Worldwide Orthopedic Market (2013E): Percentage Market Share Breakdown of Value Sales by Company for DePuy Synthes, Stryker, Zimmer, Smith & Nephew, Medtronic, and Others (includes corresponding Graph/Chart)
    • Table 18: Worldwide Market for Orthopedic Implants in Spinal Procedures (2013E): Percentage Market Share Breakdown of Value Sales by Company for Medtronic, J&J and Others (includes corresponding Graph/Chart)
    • Table 19: Worldwide Market for Orthopedic Implants for Reconstructive Procedures (2013E): Percentage Market Share Breakdown of Value Sales by Company for Zimmer, J&J, Stryker, Biomet, Smith & Nephew, and Others (includes corresponding Graph/Chart)
    • Table 20: Worldwide Market for Orthopedic Implants for Trauma Procedures (2013E): Percentage Market Share Breakdown of Value Sales by Company for J&J, Stryker, Biomet Smith & Nephew, Zimmer, and Others (includes corresponding Graph/Chart)
    • Table 21: Global Joint Replacement Market (2013E): Percentage Market Share Breakdown of Sales for Zimmer, DePuy Synthes, Stryker, Biomet, Smith & Nephew, and Others (includes corresponding Graph/Chart)
  • Orthopedic Grafts - Regional Market Variations

2. MARKET TRENDS

  • Combined Organ Transplantation - Gaining Attention
    • Table 22: Multiple Organ Transplants in the US - No. of Transplants by Type (2010-2014)
  • Illegal Organ Trafficking - A Risky Proposition
  • Increasing Consent Rates - A Key Factor
  • Transplant Tourism - Creating Brighter Avenues
  • Alliances to Play a Key Role
  • Graying Population and Chronic Diseases Surge Need for Transplants
    • Table 23: Aged Population (65+ Years) as a Percentage of the Total Population: 2000 Vis-a-vis 2025 (includes corresponding Graph/Chart)
    • Table 24: Aged Population (65+ Years) as a Percentage of the Total Population by Region: 2000 Vis-a-vis 2025 (includes corresponding Graph/Chart)
    • Table 25: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 26: Aging Population by Age Group in More Developed Countries: 1975-2050 (includes corresponding Graph/Chart)
    • Table 27: Aging Population by Age Group in Less Developed Countries: 1975-2050 (includes corresponding Graph/Chart)
    • Table 28: Aging Population by Age Group in Least Developed Countries: 1975-2050 (includes corresponding Graph/Chart)
  • Rising Incidences of Degenerative Intervertebral Disc Diseases Promote Tissue Transplantation
    • Table 29: % of Women Affected by Osteoporosis (includes corresponding Graph/Chart)
  • Fetal Tissue for Bionic Devices - Assuming Importance
  • LVADs - Gaining Significance for Impending Heart Transplants
  • Stem Cell Based Bone Grafts - Fastest Growing Bone Graft Substitute Segment
  • Synthetic Bone Graft - The Latest Trend
  • Stem Cell Therapies - Expanding the Horizon of Transplantation
  • Rising Cancer Incidence to Drive Stem Cell Transplants
    • Table 30: Number of New Cancer Cases Worldwide by Affected Site: 2012 (in Thousands) (includes corresponding Graph/Chart)
  • Demineralized Bone Matrix (DBM): Strong Growth but Tough Competition
  • Bone Morphogenetic Protein - Safety Concerns Affect Growth Prospects
  • Dental Bone Grafting - A High Potential Market
    • Table 31: Global Dental Regeneration Market (2013E): Percentage Share Breakdown of Value Sales for Bone Allografts, Membranes, Tissue Regeneration (includes corresponding Graph/Chart)

3. TECHNOLOGICAL INNOVATIONS

  • 3-D Bioprinting
  • Preloaded Corneal Tissue Cartridges
  • Lung Perfusion Technology

4. MAJOR ISSUES IMPACTING TRANSPLANTATION MARKET

  • Organ Rejection - A Major Barrier to Transplantation
  • Scarcity of Donor Organs - A Stumbling Block in Organ Transplantation
  • Other Issues for Organ Transplantation
  • Ethical Concerns in Transplants
  • Bioethical Issues Hinder Organ Donation Process
  • Lack of Requisite Expertise - Hindering Implantation Process
  • Corneal Transplantation in Developing Countries: Key Challenges

5. PRODUCT OVERVIEW

  • Organ Transplantation
  • Heart Transplantation
    • Heart Diseases and Disorders
    • Post-Operative Complications and Consequences of Heart Transplants
      • Bleeding
      • Infection
      • Arrythymia
      • Heart Attack
      • Coronary Artery Disease
      • Respiratory Dysfunction
      • Renal Dysfunction
      • Graft Rejection and Dysfunction
      • Death
  • Kidney Transplantation
    • Kidney Disorders and Diseases
    • Donor Evaluation
    • Waiting List
    • Surgery/Post-Operation
    • Post-Operative Supervision and Issues
  • Liver Transplantation
    • Liver Disorders and Diseases
  • Pancreas Transplantation
    • Post-Operative Complications and Consequences of Pancreas Transplants
  • Small Intestine Transplantation
    • Intestine Disorders and Diseases
  • Heart-and-Lung Transplantation
  • Lung Transplantation
    • Lung Diseases and Disorders
    • Lung Patients Survival Statistics
  • Tissue Transplantation
  • Types of Grafts
    • Autograft
    • Allograft / Homograft
      • Transplant Tolerance
    • Isograft
    • Xenograft
  • Corneal Transplantation
    • Penetrating Keratoplasty
    • Lamellar (Non-Penetrating) Keratoplasty
    • Aftercare
    • Risks Associated with Corneal Transplants
    • Transplantation Outcomes
    • Morbidity and Mortality Rates
    • Alternatives
  • Blood Stem Cells
    • Peripheral Blood Stem Cell Transplant
    • Umbilical Cord Blood Stem Cell Transplant
    • Bone Marrow and Hematopoietic Stem Cells
  • Bone and Tissue Transplantation
  • Bone Marrow Transplants
    • Stem Cell Therapy
  • Human Heart Valves
    • Atrioventricular Valves
      • Mitral Valve
      • Tricuspid Valve
    • Semilunar Valves
      • Aortic Valve
      • Pulmonic Valve
    • Pathology of Valves
    • Prosthetic Heart Valves
    • Prosthetic Mechanical Valve
      • Advantages
      • Disadvantages
    • Prosthetic Biologic Valve
      • Advantages
      • Disadvantages
  • Fetal Cells
    • Fetal Tissue for Transplantation
  • Storage Duration Time
    • Storage Time Period for Organs and Tissues
  • Cold Ischemia Time
  • Transplantation Immunology
  • Acute Cellular Rejection
  • Chronic Rejection
  • Post Transplant Observations
  • Types of Donors
  • Alive Donors
  • Related Donors
  • Good Samaritans
  • Rewarded/Forced Donors
  • Deceased Donors
  • Directed / Allocated
    • Organs and Tissues Transplanted by Type of Donor
  • Organ/Tissue Donation and Eligibility Criteria
  • Factors Considered for Matching Recipients to Donor Organs
  • Testing
  • Blood Typing
  • Tissue Typing
  • Histocompatibility - A Major Barrier for Organ Transplantation
  • Transplantation - Safety Requirements
  • Waiting List
  • Active Waiting List Patients
  • Inactive Waiting List Patients
  • History

6. ARTIFICIAL ORGANS - AN ALTERNATIVE TO SOLID ORGAN TRANSPLANTS

  • Artificial Organs Revolutionize Medical Technology Industry
  • Artificial Organs
  • Categorization of Artificial Organs
  • External Artificial Organs
  • Internal or Implantable Artificial Devices
  • Artificial Heart
  • Total Artificial Heart (TAH)
  • Ventricle Assist Device (VAD)
    • Right Ventricular Assist Systems (RVAS)
    • Left Ventricular Assist Systems (LVAS)
      • Various Ventricle Assist Devices Approved in the Recent Past
  • Artificial Kidney (Dialyzer)
  • Limitations of Artificial Kidney
  • Artificial Liver
  • Various Liver Assist Devices
  • Categorization of Liver Devices
    • Mechanical Systems
    • Bio-Artificial Systems
  • Artificial Pancreas
  • Artificial Lungs (Oxygenator)
  • Types of Artificial Lung
  • Artificial Cornea
  • Keratoprostheses
  • Tissue Engineered Corneas
  • Artificial Skin/Skin Replacement Products
  • AlloDerm Regenerative Tissue Matrix
  • Apligraf
  • Cymetra Micronized AlloDerm Tissue
  • Dermagraft
  • Epicel
  • Integra Products
  • OrCel
  • TransCyte
  • Core Competitive Factors
  • Market Outlook for Artificial Organs

7. PRESERVATION SOLUTIONS & IMMUNOSUPPRESSANT DRUGS

  • Organ Preservation Solutions
  • Celsior Solution
  • Collins Solution
  • Euro Collins Solution
  • Custodiol(r) HTK Solution
  • Hypothermosol
  • ViaSpan
  • Immunosuppressant Drugs
  • Antibody Products for Treatment of Organ Transplant Rejection
    • Antithymocyte Globulin
    • ATGAM
    • Thymoglobulin
  • Therapeutic Antibody Products
    • Antiproliferative Agents
    • Azathioprine
    • CellCept
    • Certican
    • Myfortic
    • Calcineurin Inhibitors
      • Cyclosporine
      • Gengraf
      • Neoral
      • Prograf (Tacrolimus)
    • TOR Inhibitors
  • Side Effects of Immunosuppression Therapy
  • Select Players Engaged in Immunosuppressant Drugs/Anti-Rejection Therapy/ Bridge-to- Transplantation Devices
  • Astellas Pharma US, Inc. (USA)
  • F.Hoffmann-La Roche Ltd. (Switzerland)
  • Novartis AG (Switzerland)
  • Wyeth (USA)
  • Abiomed, Inc. (USA)
  • Fresenius Medical Care AG & Co. KGaA (Germany)
  • Gambro AB (Sweden)
  • Genzyme Corporation (US)
  • Jarvik Heart, Inc. (US)
  • ReliantHeart (US)
  • SynCardia Systems (US)
  • Terumo Corporation (Japan)
  • Teleflex Inc. (US)
  • Thoratec Corporation (US)
  • Heart Ware International, Inc. (US)

8. REGULATORY ENVIRONMENT

  • Transplant Center
  • Organ Procurement Organization (OPO)
  • Health Resources and Services Administration (HRSA)
  • Division of Transplantation (DoT)
  • United Network for Organ Sharing (UNOS)
  • Organ Procurement and Transplantation Network (OPTN)
  • University Renal Research and Education Association (URREA)
  • Scientific Registry of Transplant Recipients (SRTR)
  • Funding Sources
  • Patient Education and Advocacy Organizations
  • Legal Framework for Transplantation
  • Legislation Covering Organ Transplant
  • Organ Transplantation and Ethics

9. PRODUCT DEVELOPMENT/INNOVATIONS

  • AlloSource Introduces AlloMend(tm)
  • Synergy Biomedical Launches Bonegraft Product BioSphere Putty
  • K2M Launches Venado Bonegraft Systems
  • OTS Launches LifeCradle(r) Heart Perfusion System
  • BioHorizons Launches MinerOss(r) Cancellous Dental Grafts
  • K2M Launches Vesuvius Graft Systems
  • OTTR Launches Pediatric BMT System
  • Amedica to Begin Distribution of Dynamic Bone
  • BioMimetic Introduces Augmatix Bonegraft
  • Integra Introduces Integra(r) Allograft Wedge System

10. RECENT INDUSTRY ACTIVITY

  • ThermoGenesis and TotipotentRX Complete 20th Pediatric BMT
  • LifeCell Acquires Adipose Tissue Injector from Tau Tona Group
  • FBiH Signs Agreement with Croatia
  • AlloSource and HumaCyte Enter Manufacturing Agreement
  • PSF Partners with MTF for Research Grants
  • Wright Medical Partners with BioMimetic Therapeutics
  • Pharmalink Signs Manufacturing Agreement with GP Pharm
  • Isotechnika Pharma Ends Agreement with ILJIN
  • Veloxis Starts STRATO Study in Kidney-Transplant Recipients
  • Isotechnika Signs Voclosporin License Agreement with Vifor Pharma

11. FOCUS ON SELECT GLOBAL PLAYERS

  • CryoLife, Inc.(US)
  • Exactech, Inc. (US)
  • Folio Biosciences (US)
  • Kohler Chemie (Germany)
  • LifeCell Corporation (US)
  • Medtronic, Inc. (US)
  • Organogenesis, Inc. (US)
  • Organ Recovery Systems (US)
  • Organ Transport Systems (US)
  • XVIVO Perfusion AB (Sweden)

12. GLOBAL MARKET PERSPECTIVE

    • Table 32: World Recent Past, Current & Future Analysis for Organ Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 33: World Historic Review for Organ Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 34: World 15-Year Perspective for Organ Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 35: World Recent Past, Current & Future Analysis for Heart Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 36: World Historic Review for Heart Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 37: World 15-Year Perspective for Heart Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 38: World Recent Past, Current & Future Analysis for Kidney Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 39: World Historic Review for Kidney Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 40: World 15-Year Perspective for Kidney Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 41: World Recent Past, Current & Future Analysis for Liver Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 42: World Historic Review for Liver Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 43: World 15-Year Perspective for Liver Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 44: World Recent Past, Current & Future Analysis for Pancreas Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 45: World Historic Review for Pancreas Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 46: World 15-Year Perspective for Pancreas Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 47: World Recent Past, Current & Future Analysis for Lung Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 48: World Historic Review for Lung Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 49: World 15-Year Perspective for Lung Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 50: World Recent Past, Current & Future Analysis for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 51: World Historic Review for Corneal Transplantation by Geographic Region - US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 52: World 15-Year Perspective for Corneal Transplantation by Geographic Region - Percentage Breakdown of Number of Procedures for US, Canada, Europe, Asia-Pacific (including Japan), Latin America and Rest of World Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Organ Transplants Market in the US
    • Organ Transplants by Donor
    • Table 53: The US Organ Donors per 1 Million Population by Type - Kidney, Liver, Heart, Lung, and Pancreas for the Years 2011, 2012 & 2013 (includes corresponding Graph/Chart)
    • Table 54: The US Bone Marrow Donor Registry: Percentage Breakdown of Adult Donors and Cord Blood Units by Race/Ethnicity (includes corresponding Graph/Chart)
    • Table 55: The US Kidney Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Table 56: The US Kidney Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Table 57: The US Liver Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Table 58: The US Liver Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Table 59: The US Heart Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Table 60: The US Heart Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E
    • Table 61: The US Lung Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Table 62: The US Lung Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Table 63: The US Pancreas Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 (Aug '14) (includes corresponding Graph/Chart)
    • Table 64: The US Pancreas Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Table 65: The US Intestinal Transplants by Donor Type - Deceased and Living: Number of Procedures for 2012, 2013, and 2014 (Aug '14) (includes corresponding Graph/Chart)
    • Table 66: The US Intestinal Transplants by Donor Type - Deceased and Living: Percentage Share Breakdown of Number of Procedures for 2012, 2013, and 2014 E (includes corresponding Graph/Chart)
    • Waiting List
    • Table 67: Waiting List of Patients for Organ Transplants by Organ Type: as of August 2014 (includes corresponding Graph/Chart)
    • Select Market Trends
      • Rising Incidence of ESRD in the US: A Business Case for Kidney Transplants
    • Table 68: ESRD Patient Prevalence in the US (2010-2015) (includes corresponding Graph/Chart)
      • Innovative Means of Organ Procurement to Increase Organ Donations
      • KPD Enables Compatibility Factor for Kidney Transplants
      • Awareness Programs to Address Shortage of Minority Donors
      • US Organ Procurement Organizations by State
      • Tissue Transplantation in the US
    • Dental Bone Graft Substitutes Market: An Overview
      • Regulatory Challenges Limit Growth in the US Orthopedic Biomaterials Market
    • Rising Incidence of Degenerative Intervertebral Disc Diseases-Opportunity Indicators for Bone Grafts
      • Osteoporosis
    • Table 69: Osteoporosis Population in the US: 2002, 2005, 2008 & 2012 (includes corresponding Graph/Chart)
    • Table 70: Breakdown of Osteoporotic Fractures by Site in the US (includes corresponding Graph/Chart)
    • Regulatory Bodies
      • The United Network for Organ Sharing
      • The American Association of Tissue Banks (AATB)
      • National Organ Transplant Act (NOTA)
      • Good Tissue Practices
      • Tissue Banking Regulation
      • FDA Regulations on Xenograft
      • DBM-based Products in US
      • Synthetic Bone Graft Substitutes
    • Product Launches
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • By Value Sales
    • Table 71: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 72: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 73: The US 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Dollar Sales for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 74: The US Recent Past, Current & Future Analysis for Tissue Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 75: The US Historic Review for Tissue Transplantation Market Analyzed with Annual Sales Figures in US$ Million for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • By Number of Procedures
    • Table 76: The US Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 77: The US Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 78: The US 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas, Lung and Intestine Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 79: The US Recent Past, Current & Future Analysis for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 80: The US Historic Review for Tissue Transplantation by Tissue Type - Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 81: The US 15-Year Perspective for Tissue Transplantation by Tissue Type - Percentage Breakdown of Number of Procedures for Cornea, Heart Valves, Skin Grafts, Vascular Grafts, Bone Marrow and Bone Grafts Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 82: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 83: The US Historic Review for Bone Graft Transplantation by Graft Type - Autologous Graft, Allograft and Other Materials Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 84: The US 15-Year Perspective for Bone Graft Transplantation by Graft Type - Percentage Breakdown of Number of Procedures for Autologous Graft, Allograft and Other Materials Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)
    • Table 85: The US Recent Past, Current & Future Analysis for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 86: The US Historic Review for Bone Graft Transplantation by Application - General Orthopedics, Spinal Fusions and Cranio/ Maxillofacial Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 87: The US 15-Year Perspective for Bone Graft Transplantation by Application - Percentage Breakdown of Number of Procedures for General Orthopedics, Spinal Fusions and Cranio/Maxillofacial Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Canadians More Receptive to Organ Transplants
    • Table 88: Canadian Organ Donors by Donor Type - Deceased and Living for Years 2011& 2012 (includes corresponding Graph/Chart)
    • Table 89: Canadian Deceased Organ Donors by Age Group (2011 & 2012) (includes corresponding Graph/Chart)
    • Table 90: Canadian Living Organ Donors by Age Group (2011 & 2012) (includes corresponding Graph/Chart)
    • Table 91: Canadian Multiple Organ Transplants by Type in Terms of Number of Transplants: 2012 (includes corresponding Graph/Chart)
      • Small Intestine Transplants
    • Table 92: Canadian Intestinal Transplants by Transplant Type and Age Group (2003-2012) (includes corresponding Graph/Chart)
    • Waiting List
    • Table 93: Canadian Patients on Active Waiting List for Organ Transplants by Type: 2012 (includes corresponding Graph/Chart)
    • Table 94: Canadian Patients on Active Waiting List for Combination Organ Transplants by Type (2012) (includes corresponding Graph/Chart)
    • Success Rate of Organ Transplants
    • Table 95: Success Rate of Organ Transplants after 1-Year (includes corresponding Graph/Chart)
    • Favorable Growth Prospects in Bone Graft Substitutes Market
  • B. Market Analytics
    • Table 96: Canadian Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 97: Canadian Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 98: Canadian 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

3. EUROPE

  • A. Market Analysis
    • Table 99: European Deceased Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
    • Table 100: European Living Organ Donor Per Million Population (PMP) by Country for 2013 (includes corresponding Graph/Chart)
    • Table 101: European Single Organ Transplantations by Select Country and Organ Type: 2013 (includes corresponding Graph/Chart)
    • Table 102: European Multi-Organ Transplantations by Select Country and Transplant Type: 2013 (includes corresponding Graph/Chart)
    • Table 103: European Organ Transplantation Waiting Lists: No. of Waiting Patients by Organ Type (2012) (includes corresponding Graph/Chart)
    • Orthopedic Biomaterials Market - Overview
    • Table 104: European Bone Graft Substitutes Market (2012): Percentage Share Breakdown of Value Sales for Synthetic, Allograft, and DBM (includes corresponding Graph/Chart)
    • Synthetic Bone Graft Market Drives the BGS Market
    • Dental Biomaterials Market in Europe: An Insight
    • Medical Tourism Bodes Well for Dental Implants Market
    • Turkey - Fastest Growing Dental Implant Market
    • Competitive Scenario
    • Key Statistical Data
    • Table 105: European Market for Standard Bone Allografts (2012): Percentage Share Breakdown of Revenues by Leading Companies/Organizations (includes corresponding Graph/Chart)
    • Table 106: European Market for Machined Bone Allografts (2012): Percentage Share Breakdown of Revenues by Leading Companies/Organizations (includes corresponding Graph/Chart)
    • Table 107: European Market for Demineralized Bone Matrix (2012): Percentage Market Share Breakdown of Revenues by Leading Companies/ Organizations (includes corresponding Graph/Chart)
    • Table 108: European Market for Bone Graft Substitutes (2012): Percentage Share Breakdown of Value Sales by Leading Players (includes corresponding Graph/Chart)
    • Regulatory Overview
      • EU Directive 2003/32/EC on Bone Grafts
      • DBM-based Products in Europe & Rest of World
    • Focus On Select Regions
      • The United Kingdom
      • UK Organ Transplantation System: An Overview
      • Organ Transplantation Statistics in the UK
    • Table 109: The UK Organ Donors by Type (April 2012 & April 2013) (includes corresponding Graph/Chart)
    • Table 110: The UK Organ Transplantation by Organ Type: 2012 Vs. 2013 (includes corresponding Graph/Chart)
    • Table 111: The UK Active Transplant Waiting List by Organ: As of April 2012 and April 2013 (includes corresponding Graph/Chart)
    • Table 112: The UK Deceased Donor Kidney Program (March 2010-March 2013) - No. of Kidney Donors, No. of Patients on Active Waiting List, and No. of Kidney Transplants (includes corresponding Graph/Chart)
      • Corneal Transplantation in the UK
      • Spain
      • Organ Transplantation in Spain
      • France
    • Table 113: Organ Transplantations in France by Organ Type: 2012 (includes corresponding Graph/Chart)
    • Table 114: Transplant Waiting List by Organ in France: 2012 (includes corresponding Graph/Chart)
    • Table 115: Transplants from Living Donors by Organ Type in France: 2012 (includes corresponding Graph/Chart)
      • Italy
      • Surge in Organ Transplants
      • Russia
      • Organ Transplantations Show a Downward Trend in Russia
      • Turkey
    • Table 116: Turkey - High PMP Numbers of Living Organ Donors/Transplants (includes corresponding Graph/Chart)
      • Akdeniz University - A World-Renowned Transplantation Center
    • Strategic Corporate Developments
    • Select Key Players
  • B. Market Analytics
    • Table 117: European Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 118: European Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 119: European 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

4. ASIA-PACIFIC

  • A. Market Analysis
    • Table 120: Asia-Pacific Deceased Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
    • Table 121: Asia-Pacific Living Organ Donor Per Million Population (PMP) by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
    • Focus on Select Regions
      • Australia - One of the Major Organ Transplant Markets in Asia-Pacific
      • Key Facts on Organ and Tissue Transplantation in Australia
      • Australia Registers Highest Success Rate in Transplantation
    • Table 122: Australia Organ Transplantations by Organ Type: 2013 (includes corresponding Graph/Chart)
    • Table 123: Australian Organ Transplants by State: 2013 (includes corresponding Graph/Chart)
      • Thriving Orthopedic Biomaterials Market in Asia-Pacific
      • China
      • Organ Transplantations in China: Years 2010 to 2013 in Review
      • Origin
      • Transplantation Tourism in China
      • Low Transplant Success Rate Due to Unskilled Professionals
      • Cost Effective Transplant Procedures Lure Foreign Patients
      • Illegal Activities for Harvesting Organs in China
      • Regulations on Organ Transplantation
      • Regulations on Brain Death
      • India
      • Overview of Renal Transplantation
      • Transplantation Expenses in India
      • Indian Government to Amend Organ Transplantation Rules
      • Rise in Medical Tourism Drives Bone Grafts Market
      • Aging Population Boosts the Indian Orthopedic Market
      • Singapore
      • Awareness Programs to Increase Living Kidney Donations in Singapore
    • Terumo Corporation (Japan) - A Key Player
  • B. Market Analytics
    • Table 124: Asia-Pacific Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 125: Asia-Pacific Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 126: Asia-Pacific 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

5. LATIN AMERICA

  • A. Market Analysis
    • Brazil - A Major Transplant Market
    • Dental Bone Graft Substitutes Market - Overview
  • B. Market Analytics
    • Table 127: Latin American Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 128: Latin American Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 129: Latin American 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

6. REST OF WORLD

  • A. Market Analysis
    • Kuwait - A Rapidly Emerging 'Third World' Country in Organ Transplants
    • Iran - "Kidney E-Bay"
    • South Africa
      • Key Statistical Findings on Organ and Cornea Transplants
    • Table 130: Incidence of Deceased Organ Donor per million population in Africa/ Middle East by Country for 2011, 2012 & 2013 (includes corresponding Graph/Chart)
    • Table 131: Incidence of Living Organ Donor per million population in Africa/Middle East by Country for 2012 & 2013 (includes corresponding Graph/Chart)
    • Table 132: Number of Organ and Corneal Transplants in South Africa by Organ Type: 2011&2012 (includes corresponding Graph/Chart)
    • Table 133: Number of Organ and Corneal Transplants in Adult Patients in South Africa by Organ: 2011 & 2012 (includes corresponding Graph/Chart)
    • Table 134: Number of Organ Transplants in Adolescent Patients in South Africa by Organ: 2011&2012 (includes corresponding Graph/Chart)
    • Table 135: Number of Organ Transplants in Pediatric Patients in South Africa by Organ: 2011&2012 (includes corresponding Graph/Chart)
  • B. Market Analytics
    • Table 136: Rest of World Recent Past, Current & Future Analysis for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 137: Rest of World Historic Review for Organ Transplantation by Organ Type - Heart, Kidney, Liver, Pancreas and Lung Markets Independently Analyzed by Number of Procedures for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 138: Rest of World 15-Year Perspective for Organ Transplantation by Organ Type - Percentage Breakdown of Number of Procedures for Heart, Kidney, Liver, Pancreas and Lung Markets for Years 2006, 2014 & 2020 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top